HEALTHCO HEALTHCARE & WELLNESS REIT (HCW)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

HCW

HCW - HEALTHCO HEALTHCARE & WELLNESS REIT

FNArena Sector : REITs
Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 12.42
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.67

11 Feb
2026

-0.020

OPEN

$0.70

-2.90%

HIGH

$0.70

5,611,824

LOW

$0.65

TARGET
$0.858 28.0% upside
OTHER COMPANIES IN THE SAME SECTOR
ABG . AOF . ARF . ASK . BWP . CDP . CDP . CHC . CIP . CLW . COF . CQE . CQR . DGT . DXC . DXI . DXS . GDF . GDI . HDN . NSR . PLG . REP . RFF . RGN . SCG . TGP . VCX . WOT . WPR .
FNARENA'S MARKET CONSENSUS FORECASTS
HCW: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx - 16.0 7.1 xxx
DPS (cps) xxx 4.2 3.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx - 47.5% - 28.6% xxx
PE Ratio xxx N/A 9.5 xxx
Dividend Yield xxx N/A 4.5% xxx
Div Pay Ratio(%) xxx N/A 42.6% xxx

Dividend yield today if purchased 3 years ago: 2.60%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

6.27

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 30/12 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202320242025
EPS Basic 5.41.2-16.0
DPS All 7.68.04.2
Sales/Revenue 49.1 M73.8 M61.5 M
Book Value Per Share 169.0162.5143.2
Net Operating Cash Flow 11.1 M15.2 M33.2 M
Net Profit Margin 41.14 %9.35 %-144.39 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202320242025
Return on Capital Employed 2.52 %0.74 %-10.44 %
Return on Invested Capital 1.73 %0.45 %-8.13 %
Return on Assets 1.67 %0.44 %-6.54 %
Return on Equity 2.52 %0.74 %-10.44 %
Return on Total Capital 4.49 %3.23 %2.73 %
Free Cash Flow ex dividends -18.4 M-29.9 M-1.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202320242025
Short-Term Debt 0 M0 M445 M
Long Term Debt 704 M481 M3 M
Total Debt 704 M481 M448 M
Goodwill - Gross ---
Cash & Equivalents - Generic 8 M20 M41 M
Price To Book Value 0.780.650.51

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202320242025
Capex 0.0 M0.0 M0.0 M
Capex % of Sales 0.00 %0.00 %0.00 %
Cost of Goods Sold 16 M17 M17 M
Selling, General & Admin. Exp & Other -19 M7 M9 M
Research & Development ---
Investments - Total 1,647 M1,009 M890 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

15/10/2025

5

Underweight

$0.89

32.84%

Morgan Stanley has outlined potential catalysts for Australian real estate stocks expected to emerge during the December 2025 and March 2026 quarters.

For HealthCo Healthcare & Wellness REIT, finalisation of the Healthscope hospital sale process is expected in 2Q26, with outcomes likely in line with the broker's expectations.

Healthscope accounts for more than half of the REIT’s rental income, note the analysts. Any rent revision is expected to be lower, with additional lease incentives likely.

Underweight rating. Target price 89c. Industry view: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY26 dividend of 9.00 cents and EPS of 9.00 cents.
Morgan Stanley forecasts a full year FY27 dividend of 8.00 cents and EPS of 8.00 cents.

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

HCW STOCK CHART